Boultwood J - Search Results

1

Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q.

Adema V, Palomo L, Walter W, Mallo M, Hutter S, La Framboise T, Arenillas L, Meggendorfer M, Radivoyevitch T, Xicoy B, Pellagatti A, Haferlach C, Boultwood J, Kern W, Visconte V, Sekeres M, Barnard J, Haferlach T, Solé F, Maciejewski JP. Adema V, et al. Among authors: boultwood j. EBioMedicine. 2022 Jun;80:104059. doi: 10.1016/j.ebiom.2022.104059. Epub 2022 May 23. EBioMedicine. 2022. PMID: 35617825 Free PMC article.

2

Homozygous deletion of FMS in a patient with the 5q- syndrome.

Boultwood J, Rack K, Buckle VJ, Kelly S, Madden J, Oscier DG, Wainscoat JS. Boultwood J, et al. Br J Haematol. 1990 Oct;76(2):310-1. doi: 10.1111/j.1365-2141.1990.tb07892.x. Br J Haematol. 1990. PMID: 2094336 No abstract available.

3

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.

Lewis S, Oscier D, Boultwood J, Ross F, Fitchett M, Rack K, Abrahamson G, Buckle V, Wainscoat JS. Lewis S, et al. Among authors: boultwood j. Am J Hematol. 1995 Jul;49(3):194-200. doi: 10.1002/ajh.2830490304. Am J Hematol. 1995. PMID: 7604812

4

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.

Boultwood J, Fidler C, Lewis S, MacCarthy A, Sheridan H, Kelly S, Oscier D, Buckle VJ, Wainscoat JS. Boultwood J, et al. Blood. 1993 Nov 1;82(9):2611-6. Blood. 1993. PMID: 8219215 Free article.

5

Molecular characterization of the 7q deletion in myeloid disorders.

Lewis S, Abrahamson G, Boultwood J, Fidler C, Potter A, Wainscoat JS. Lewis S, et al. Among authors: boultwood j. Br J Haematol. 1996 Apr;93(1):75-80. doi: 10.1046/j.1365-2141.1996.4841025.x. Br J Haematol. 1996. PMID: 8611479

6

Novel genes mapping to the critical region of the 5q- syndrome.

Boultwood J, Fidler C, Soularue P, Strickson AJ, Kostrzewa M, Jaju RJ, Cotter FE, Fairweather N, Monaco AP, Müller U, Lovett M, Jabs EW, Auffray C, Wainscoat JS. Boultwood J, et al. Genomics. 1997 Oct 1;45(1):88-96. doi: 10.1006/geno.1997.4899. Genomics. 1997. PMID: 9339364 Free article.

7

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.

Jaju RJ, Boultwood J, Oliver FJ, Kostrzewa M, Fidler C, Parker N, McPherson JD, Morris SW, Müller U, Wainscoat JS, Kearney L. Jaju RJ, et al. Among authors: boultwood j. Genes Chromosomes Cancer. 1998 Jul;22(3):251-6. doi: 10.1002/(sici)1098-2264(199807)22:3<251::aid-gcc11>3.0.co;2-r. Genes Chromosomes Cancer. 1998. PMID: 9624537

8

Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.

Jaju RJ, Jones M, Boultwood J, Kelly S, Mason DY, Wainscoat JS, Kearney L. Jaju RJ, et al. Among authors: boultwood j. Genes Chromosomes Cancer. 2000 Nov;29(3):276-80. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1035>3.0.co;2-l. Genes Chromosomes Cancer. 2000. PMID: 10992302

9

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome.

Boultwood J, Fidler C, Strickson AJ, Watkins F, Gama S, Kearney L, Tosi S, Kasprzyk A, Cheng JF, Jaju RJ, Wainscoat JS. Boultwood J, et al. Blood. 2002 Jun 15;99(12):4638-41. doi: 10.1182/blood.v99.12.4638. Blood. 2002. PMID: 12036901 Free article.

10

Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS).

Gibbons RJ, Pellagatti A, Garrick D, Wood WG, Malik N, Ayyub H, Langford C, Boultwood J, Wainscoat JS, Higgs DR. Gibbons RJ, et al. Among authors: boultwood j. Nat Genet. 2003 Aug;34(4):446-9. doi: 10.1038/ng1213. Nat Genet. 2003. PMID: 12858175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page